Q4 2024 BWX Technologies Inc Earnings Call Transcript
Key Points
- BWX Technologies Inc (BWXT) reported record revenue, adjusted EBITDA, adjusted earnings per share, and free cash flow for 2024, meeting or exceeding their full-year guidance.
- The company ended 2024 with a backlog of $4.8 billion, up 21% year over year, driven by large contract awards in both operating segments.
- BWXT is strategically investing in expanding its capabilities, including the completion of the BWXT Innovation campus and the acquisition of AOT, enhancing its special materials business line.
- The commercial operations segment saw double-digit revenue and adjusted EBITDA growth, with strong performance in commercial power and medical markets.
- BWXT Medical achieved a 23% revenue growth in 2024, with EBITDA turning more meaningfully positive, driven by increased sales of therapeutic isotopes and new commercial agreements.
- Adjusted EBITDA for the fourth quarter was $130 million, down from $148 million in the same quarter last year, due to lower government operations and timing of corporate expense accruals.
- The government operations segment experienced a slight revenue decline in the fourth quarter, with adjusted EBITDA margin down due to a tough comparison and shifting mix toward less mature programs.
- BWXT faces potential tariff risks, particularly in its medical business, which could impact pricing and customer relationships.
- The company anticipates a slight increase in its tax rate for 2025 due to a geographical earnings mix shift toward Canada, a higher tax jurisdiction.
- There are concerns about potential delays in new programs and starts due to changes in the regulatory environment and the prospect of a full-year continuing resolution (CR) in government funding.
Please wait, the conference will begin shortly. Ladies and gentlemen, welcome to BWX Technologies' fourth-quarter and full-year 2024 earnings conference call. (Operator Instructions)
I would now like to turn the call over to our host, Chase Jacobson, BWXT's Vice President of Investor Relations. Please go ahead.
Thank you, Gail. Good evening and welcome to today's call. Joining me are Rex Geveden, President and CEO; and Robb LeMasters, Executive Vice President and CFO. On today's call, we will reference the fourth quarter 2024 earnings presentation that is available on the investor section of the BWXT website. We will also discuss certain matters that constitute forward-looking statements. These statements involve risks and uncertainties, including those described in the Safe Harbor provisions found in the investor materials in the company's SEC filings.
We will frequently discuss non-GAAP financial measures, which are reconciled to GAPP measures in the appendix of the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
